-

SignalPath Expands Leadership Team with Key Hire to Lead Finance

RALEIGH, N.C.--(BUSINESS WIRE)--SignalPath today announced that Daniel Janick has joined SignalPath as Senior Vice President of Finance, to support the explosive growth of the SignalPath platform across both its site and sponsor client segments.

“I am encouraged to see the continued adoption of our site-facing CTMS platform across a broad spectrum of sites, health systems, and academic medical centers over the last several months,” says Dr. Brad Hirsch, Chief Executive Officer at SignalPath. “Now that we are beginning to see similar excitement with our sponsor-facing tools, it became clear that we needed to augment our leadership team with someone with deep strategic finance expertise.”

Dan brings to SignalPath a 30-year track record of successfully building enterprise value and driving execution for tech-enabled businesses as a C-suite leader, board member, investor, and financial advisor. Most recently, Dan served for eight years as Chief Operations Officer and Chief Financial Officer at Academic Analytics where he helped lead the technology company’s transition from early stage to sustainable growth and profitability. Dan also has extensive experience in private equity and investment banking where he has spent his career doing strategic investments, mergers, and acquisitions.

“SignalPath’s vision for bringing innovative technology solutions to the clinical research market could not be more relevant given the challenges of the current global pandemic,” says Dan Janick. “I’m excited to join SignalPath’s dynamic leadership team and be part of the company’s next phase of aggressive growth.”

About SignalPath: SignalPath is the premier clinical trial technology partner for research sites and sponsors, focused on improving the ease and efficiency of trial execution and management. Supporting over 2,500 trials across 300 sites and 3,000 active users, SignalPath is the industry standard that addresses key pain points in the conduct of trials. To learn more about SignalPath's site and trial solutions, please visit www.signalpath.com.

Contacts

Daniel Quinn
SignalPath LLC
919-355-0460
media@signalpath.com

SignalPath

Details
Headquarters: Raleigh, North Carolina
CEO: Brad Hirsch
Employees: 100
Organization: PRI

Release Versions

Contacts

Daniel Quinn
SignalPath LLC
919-355-0460
media@signalpath.com

Social Media Profiles
More News From SignalPath

Quantum Leap and SignalPath Partner to Integrate Clinical Trial Software Infrastructure Across I-SPY Platform Trials

SAN FRANCISCO, CA & RALEIGH, NC--(BUSINESS WIRE)--Quantum Leap Healthcare Cooperative (Quantum Leap) and SignalPath announced a partnership today that will further empower the I-SPY platform trials with robust, streamlined technology infrastructure to drive the ease and efficiency of trial execution. SignalPath will integrate existing workflow tools being used to power the I-SPY trials into SignalPath’s research operations and financial platform. Based on the public health emergency surrounding...

Andy Corts Joins SignalPath Executive Team to Lead Research Strategy

RALEIGH, N.C.--(BUSINESS WIRE)--SignalPath today announced another key addition to their executive team. Andy Corts has joined SignalPath as Senior Vice President of Sponsor and CRO Solutions. Mr. Corts brings over 20 years of healthcare IT strategy and execution expertise in the provider, payor, and life science industries. Most recently, Corts was the Chief Information Officer at Sarah Cannon, the Cancer Institute of HCA Healthcare. In that role, he led the development of their clinical trial...
Back to Newsroom